Sandoz

Novartis CEO Vas Narasimhan

In the first quarter of 2024, Novartis increased sales by ten percent from 10.8 billion dollars in the previous year to around 11.8 billion dollars. At constant exchange rates, growth even amounted to eleven per cent. Volume increases of 14 percentage points had a positive impact on sales development. Competition from...

Remo Steenbergen, new CFO Sandoz

The Board of Directors of Sandoz announced that it will nominate Mathai Mammen, M.D., Ph.D., and Michael Rechsteiner for election to the Board at the Annual General Meeting on April 30, 2024. At the same time, Sandoz announced that Remco Steenbergen, currently a member of the Sandoz Board of Directors, will become a...

CEO Richard Saynor

Sandoz signed a Memorandum of Understanding (MOU) to build a new biologics production plant in Lendava, Slovenia. The investment is expected to be at least $400 million, supporting the company’s ambition to drive the future growth of its global biosimilars portfolio. This represents one of the largest-ever...